A-LiNK: Improving Outcomes in Autoimmune Liver Disease

Recruiting Observational Study
Autoimmune Hepatitis Primary Sclerosing Cholangitis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
800 (estimated)
Sponsor
Children's Hospital Medical Center, Cincinnati · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The Autoimmune Liver disease Network for Kids (A-LiNK) is a multi-institutional group with the mission to deliver the best care to kids with pediatric autoimmune liver disease (AILD). This study will establish a shared clinical registry and a learning health network for the participating sites focusing on collecting and transmitting clinical measurement data, information about processes, and part…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Clinical diagnosis of autoimmune hepatitis (AIH) * Clinical diagnosis of primary sclerosing cholangitis (PSC) * Clinical diagnosis of autoimmune sclerosing cholangitis (ASC) Exclusion Criteria: • History of liver transplant
Contacts

Amy E Taylor, MD

513-636-4415

amy.taylor@cchmc.org

CONTACT

Cyd M Castro-Rojas, PhD

5135170580

cyd.castrorojas@cchmc.org

CONTACT